Mikael Dolsten is President R&D of PFIZER INC. Currently has a direct ownership of 321,729 shares of PFE, which is worth approximately $8.6 Million. The most recent transaction as insider was on Sep 13, 2018, when has been sold 181,712 shares (Common Stock) at a price of $26.63 per share, resulting in proceeds of $4,838,990. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 322K
0% 3M change
9.15% 12M change
Total Value Held $8.6 Million

Mikael Dolsten Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2018
BUY
Exercise of conversion of derivative security
$4,838,990 $26.63 p/Share
181,712 Added 43.68%
234,299 Common Stock

Also insider at

A
AGILENT TECHNOLOGIES, INC. Healthcare
RCKT
ROCKET PHARMACEUTICALS, INC. Healthcare
KPTI
Karyopharm Therapeutics Inc. Healthcare
MD

Mikael Dolsten

President R&D
New York, NY

Track Institutional and Insider Activities on PFE

Follow PFIZER INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PFE shares.

Notify only if

Insider Trading

Get notified when an Pfizer Inc insider buys or sells PFE shares.

Notify only if

News

Receive news related to PFIZER INC

Track Activities on PFE